|
1.
|
Garcia M, Jemal A, Ward EM, Center MM, Hao
Y, Siegel RL and Thun MJ: Global Cancer Facts and Figures 2007.
American Cancer Society; Atlanta, GA: 2007
|
|
2.
|
Chu DZ, Lang NP, Thompson C, Osteen PK and
Westbrook KC: Peritoneal carcinomatosis in non gynecologic
malignancy. A prospective study of prognostic factors. Cancer.
63:364–367. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Yonemura Y, Kawamura T, Bandou E,
Tsukiyama G, Endou Y and Miura M: The natural history of free
cancer cells in the peritoneal cavity. Advances in Peritoneal
Surface Oncology. Gonzalez-Moreno S: Springer; Berlin: pp. 11–23.
2007, View Article : Google Scholar
|
|
4.
|
Kotanagi H, Saito Y, Shiozawa N and Koyama
K: Establishment of a human cancer cell line with high potential
for peritoneal dissemination. J Gastroenterol. 30:437–438. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Yanagihara K, Takigahira M, Tanaka H, et
al: Development and biological analysis of peritoneal metastasis
mouse models for human scirrhous stomach cancer. Cancer Sci.
96:323–332. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Takei Y, Takigahira M, Mihara K, Tarumi Y
and Yanagihara K: The metastasis-associated microRNA miR-516a-3p is
a novel therapeutic target for inhibiting peritoneal dissemination
of human scirrhous gastric cancer. Cancer Res. 71:1442–1453. 2010.
View Article : Google Scholar
|
|
7.
|
Wang GL and Semenza GL: General
involvement of hypoxiainducible factor 1 in transcriptional
response to hypoxia. Proc Natl Acad Sci USA. 90:4304–4308. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Semenza GL: HIF-1 and tumor progression:
pathophysiology and therapeutics. Trends Mol Med. 8:S62–7. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar
|
|
10.
|
Kitajima Y and Miyazaki K: The critical
impact of HIF-1α on gastric cancer biology. Cancers. 5:15–26.
2013.
|
|
11.
|
Sumiyoshi Y, Kakeji Y, Egashira A,
Mizokami K, Orita H and Maehara Y: Overexpression of
hypoxia-inducible factor 1α and p53 is a marker for an unfavorable
prognosis in gastric cancer. Clin Cancer Res. 12:5112–5117.
2006.
|
|
12.
|
Koukourakis MI, Giatromanolaki A,
Skarlatos J, et al: Hypoxia inducible factor (HIF-1α and HIF-2α)
expression in early esophageal cancer and response to photodynamic
therapy and radiotherapy. Cancer Res. 61:1830–1832. 2001.
|
|
13.
|
Bos R, van der Groep P, Greijer AE, et al:
Levels of hypoxiainducible factor-1α independently predict
prognosis in patients with lymph node negative breast carcinoma.
Cancer. 97:1573–1581. 2003.
|
|
14.
|
Nakanishi K, Hiroi S, Tominaga S, et al:
Expression of hypoxiainducible factor-1α protein predicts survival
in patients with tranitional cell carcinoma of the upper urinary
tract. Clin Cancer Res. 11:2583–2590. 2005.
|
|
15.
|
Birner P, Schindl M, Obermair A,
Breitenecker G and Oberhuber G: Expression of hypoxia-inducible
factor 1α in epithelial ovarian tumors: its impact on prognosis and
on response to chemotherapy. Clin Cancer Res. 7:1661–1668.
2001.
|
|
16.
|
Nakamura J, Kitajima Y, Kai K, Hashiguchi
K, Hiraki M, Noshiro H and Miyazaki K: HIF-1alpha is an unfavorable
determinant of relapse in gastric cancer patients who underwent
curative surgery followed by adjuvant 5-FU chemotherapy. Int J
Cancer. 127:1158–1171. 2010. View Article : Google Scholar
|
|
17.
|
Ide T, Kitajima Y, Miyoshi A, et al:
Tumor-stromal cell interaction under hypoxia increases the
invasiveness of pancreatic cancer cells through the hepatocyte
growth factor/c-Met pathway. Int J Cancer. 119:2750–2759. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kitajima Y, Ide T, Ohtsuka T and Miyazaki
K: Induction of hepatocyte growth factor activator gene expression
under hypoxia activates the hepatocyte growth factor/c-Met system
via hypoxia inducible factor-1 in pancreatic cancer. Cancer Sci.
99:1341–1347. 2008. View Article : Google Scholar
|
|
19.
|
Liu L, Sun L, Zhang H, et al:
Hypoxia-mediated up-regulation of MGr1-Ag/37LRP in gastric cancers
occurs via hypoxiainducible-factor 1-dependent mechanism and
contributes to drug resistance. Int J Cancer. 124:1707–1715. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Song IS, Wang AG, Yoon SY, Kim JM, Kim JH,
Lee DS and Kim NS: Regulation of glucose metabolism-related genes
and VEGF by HIF-1α and HIF-1β, but not HIF-2α, in gastric cancer.
Exp Mol Med. 41:51–58. 2009.
|
|
21.
|
Zhang R, Fu H, Chen D, Hua J, Hu Y, Sun K
and Sun X: Subcellular distribution of S100A4 and its
transcriptional regulation under hypoxic conditions in gastric
cancer cell line BGC823. Cancer Sci. 101:1141–1146. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Liu L, Ning X, Sun L, et al:
Hypoxia-inducible factor-1α contributes to hypoxia-induced
chemoresistance in gastric cancer. Cancer Sci. 99:121–128.
2008.
|
|
23.
|
Miyoshi A, Kitajima Y, Ide T, et al:
Hypoxia accelerates cancer invasion of hepatoma cells by
upregulating MMP expression in an HIF-1α-independent manner. Int J
Oncol. 29:1533–1539. 2006.PubMed/NCBI
|
|
24.
|
Xin L and Yibin K: Hypoxia and
hypoxia-inducible factors: master regulators of metastasis. Clin
Cancer Res. 16:5928–5935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Hiraki M, Kitajima Y, Kai K, Nakamura J,
Hashiguchi K, Noshiro H and Miyazaki K: Knockdown of
hypoxia-inducible factor-1a accelerates peritoneal dissemination
via the upregulation of MMP-1 expression in gastric cancer cell
lines. Exp Ther Med. 4:355–362. 2012.PubMed/NCBI
|
|
26.
|
Liotta LY: Tumor invasion and metastases -
role of the extra-cellular matirix: Rhoads Memorial Award lecture.
Cancer Res. 46:1–7. 1986.PubMed/NCBI
|
|
27.
|
Kawamura T, Endo Y, Yonemura Y, et al:
Significance of integrin alpha2/beta1 in peritoneal dissemination
of a human gastric cancer xenograft model. Int J Oncol. 18:809–815.
2001.PubMed/NCBI
|
|
28.
|
Stoeltzing O, McCarty MF, Wey JS, et al:
Role of hypoxiainducible factor 1alpha in gastric cancer cell
growth, angiogenesis and vessel maturation. J Natl Cancer Inst.
96:946–956. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Albrecht I and Christofori G: Molecular
mechanisms of lymphangiogenesis in development and cancer. Int J
Dev Biol. 55:483–494. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Silverman MP: The subperitoneal space:
mechanisms of tumor spread in the peritoneal cavity, mesentery and
omentum. Cancer Imaging. 4:25–29. 2003. View Article : Google Scholar : PubMed/NCBI
|
